Back
Johnson & Johnson Vs. AbbVie Industry Stock Comparison
Sell
47
JNJ
Johnson & Johnson
Last Price:
154.51
Seasonality Move:
0.86%
Sell
40
ABBV
AbbVie
Last Price:
181.14
Seasonality Move:
6.07%
Sell
47
Johnson & Johnson (JNJ)
is a Sell
Is Johnson & Johnson a Buy, Sell or Hold?
- The current Johnson & Johnson [JNJ] share price is $155.78. The Score for JNJ is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- JNJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $177.06. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $155.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JNJ is experiencing slight selling pressure.
ABBV Stock Price Chart
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.74 | Sell |
| Relative Strength Index (14 RSI): | 45.68 | Sell |
| Chaikin Money Flow: | -3897073 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (153.7 - 161.26) | Sell |
| Bollinger Bands (100): | (154.58 - 164.6) | Sell |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.88 | Sell |
| Relative Strength Index (14 RSI): | 43.25 | Sell |
| Chaikin Money Flow: | -10091734 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (171.12 - 198.68) | Sell |
| Bollinger Bands (100): | (176.92 - 198.56) | Sell |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 154.15 | Buy |
| 20-day SMA: | 156.07 | Sell |
| 50-day SMA: | 160.03 | Sell |
| 200-day SMA: | 155.8 | Sell |
| 8-day EMA: | 154.82 | Buy |
| 20-day EMA: | 156.15 | Sell |
| 50-day EMA: | 158.4 | Sell |
| 200-day EMA: | 157.56 | Sell |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 170.12 | Buy |
| 20-day SMA: | 183.93 | Sell |
| 50-day SMA: | 189.22 | Sell |
| 200-day SMA: | 178.81 | Sell |
| 8-day EMA: | 173.96 | Buy |
| 20-day EMA: | 179.62 | Sell |
| 50-day EMA: | 185.52 | Sell |
| 200-day EMA: | 178.56 | Sell |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.67 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
Johnson & Johnson Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||